EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

First report of Tunisian patients with CDKL5 ‐related encephalopathy

Chahnez Charfi Triki iD, Salma Zouari Mallouli iD, Marwa Ben Jdila, Mariem Ben Said iD, Fatma Kamoun Feki iD, Sarah Weckhuysen, Sabeur Masmoudi, Faiza Fakhfakh

Epilepsia Open · 2024

DOI: 10.1002/epi4.12824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2024. Verfasst von Chahnez Charfi Triki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Child Neurology Department, Hedi Chaker Sfax University Hospital, and Research Laboratory LR19ES15, University of Sfax, Sfax, Tunisia. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Spasms, Infantile. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mutations in the cyclin‐dependent kinase‐like 5 gene (CDKL5) are associated with a wide spectrum of clinical presentations. Early‐onset epileptic encephalopathy (EOEE) is the most recognized phenotype. Here we describe phenotypic features in eight Tunisian patients with CDKL5‐related encephalopathy.

Methods

We included all cases with clinical features consistent with CDKL5‐related encephalopathy: infantile epileptic spasm, acquired microcephaly, movement disorders and visual impairment. We collected data about seizure types, electroencephalogram, magnetic resonance imaging, and metabolic analysis. The diagnosis of CDKL5 mutation was made thanks to Sanger sequencing with an ABI PRISM 3100‐Avant automated DNA sequencer using a Big Dye Terminator Cycle Sequencing Reaction Kit v1.1. and Next Generation Sequencing (NGS) since the development of a gene panel responsible for DEE within the framework of “Strengthening the Sfax University Expertise for diagnosis and management of epileptic encephalopathies”.

Results

We collected four boys and four girls aged meanly 6 years old with confirmed mutation on CDKL5 gene. Overall, we identified five de novo CDKL5 mutations including three Frame‐shift mutations, one missense mutation, and a splicing variant. The mean age at first seizure onset was 4 months. The first seizure type was infantile epileptic spasm (4/8) followed by tonic (2/8) and myoclonic seizures (2/8). Out of eight cases, four exhibited two stages epileptic course while epilepsy in three other patients progressed on three stages. Regarding development, most cases (6/8) had psychomotor retardation from the start whilst the two others showed psychomotor regression with the onset of seizures. Additional clinical features included visual impairment (7/8), tone abnormalities (7/8), stereotypies (7/8), and acquired microcephaly (6/8). Significance Our present report delineates an unusual phenotype of CDKL5‐related encephalopathy with male gender predominance and delayed onset epilepsy. It interestingly described new phenotypic features and uncommon benign developmental profiles in boys, different patterns of CDKL5‐epilepsy, neuroimaging findings, and CDKL5 mutational spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesSpasms, InfantileChildChild, PreschoolFemaleHumansInfantMaleBrain DiseasesElectroencephalographyEpilepsyEpileptic SyndromesMagnetic Resonance ImagingMicrocephalyMutationPhenotypeTunisiaAdolescent

Stichwörter der Autor:innen

CDKL5 mutationclinical featuresdevelopmental and epileptic encephalopathyepileptic spasm

Substanzen

CDKL5 protein, humanProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Child Neurology Department, Hedi Chaker Sfax University Hospital, and Research Laboratory LR19ES15, University of Sfax, Sfax, Tunisia.
  • Laboratory of Molecular and Functional Genetics, Faculty of Science of Sfax, University of Sfax, Sfax, Tunisia.
  • Laboratory of Molecular and Cellular Screening Processes (LPCMC), Center of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.
  • Applied & Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, University of Antwerp, Antwerp, Belgium.
  • Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
  • Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.

ORCID-Profile: Chahnez Charfi Triki, Salma Zouari Mallouli, Mariem Ben Said, Fatma Kamoun Feki

Zitieren

APA

Charfi Triki, C., Zouari Mallouli, S., Ben Jdila, M., Ben Said, M., Kamoun Feki, F., Weckhuysen, S., Masmoudi, S., & Fakhfakh, F. (2024). First report of Tunisian patients with CDKL5 ‐related encephalopathy. Epilepsia Open. https://doi.org/10.1002/epi4.12824

Vancouver

Charfi Triki C, Zouari Mallouli S, Ben Jdila M, Ben Said M, Kamoun Feki F, Weckhuysen S, et al. First report of Tunisian patients with CDKL5 ‐related encephalopathy. Epilepsia Open. 2024. doi:10.1002/epi4.12824

BibTeX
@article{CharfiTriki2024,
  author = {Charfi Triki, Chahnez and Zouari Mallouli, Salma and Ben Jdila, Marwa and Ben Said, Mariem and Kamoun Feki, Fatma and Weckhuysen, Sarah and Masmoudi, Sabeur and Fakhfakh, Faiza},
  title = {First report of Tunisian patients with CDKL5 ‐related encephalopathy},
  journal = {Epilepsia Open},
  year = {2024},
  doi = {10.1002/epi4.12824}
}
Kostenlos starten →